Department of Otorhinolaryngology - Head and Neck Surgery, University of Brescia, Italy.
Department of Otorhinolaryngology - Head and Neck Surgery, University of Brescia, Italy.
Oral Oncol. 2021 Jan;112:105076. doi: 10.1016/j.oraloncology.2020.105076. Epub 2020 Oct 30.
Despite differences in oncological behavior, the 8th edition of AJCC TNM staging currently proposes the same N-classification for major salivary glands (MSG) carcinoma and squamous cell carcinoma of the upper aerodigestive tract. The present study aims to investigate a more reliable definition of N-categories for MSG carcinoma.
A retrospective multicenter study was performed, including 307 patients treated for primary MSG carcinoma from 1995 to 2019. Outcome measures included overall survival (OS), disease specific survival, and local, regional, and distant recurrence. Survival analysis was performed using log-rank test and Cox proportional-hazards model. Overall number (ON) and largest diameter (LD) of nodal metastases, including intra-parotid metastases, were considered to develop three novel proposals of N-classification; their performance were compared with the current TNM staging using Akaike information criterion (AIC), Bayesian information criterion (BIC), and Nagelkerke pseudo-R.
Intra-parotid nodes, ON and LD of nodal metastases emerged as major prognosticators for OS, while extra-nodal extension did not impact on any survival. The current N-classification did not show a satisfactory OS stratification. Three novel N-classifications were developed according to number of metastatic nodes (0 vs 1-3 vs ≥ 4) and/or their maximum diameter (<20 mm vs ≥ 20 mm). They all showed better accuracy in OS stratification, and achieved better AIC, BIC and Nagelkerke pseudo-R indices when compared to current N-classification.
All the proposed N-classifications improved OS stratification and could help in defining a specific N-classification for MSG carcinoma. Their validation and assessment in an external cohort is needed.
尽管在肿瘤学行为上存在差异,但第 8 版 AJCC TNM 分期目前仍为大涎腺(MSG)癌和上呼吸消化道鳞癌提出了相同的 N 分类。本研究旨在为 MSG 癌更可靠的 N 分期定义。
回顾性多中心研究,纳入了 1995 年至 2019 年间 307 例原发性 MSG 癌患者。研究终点包括总生存期(OS)、疾病特异性生存率和局部、区域和远处复发。采用对数秩检验和 Cox 比例风险模型进行生存分析。考虑到包括腮腺内转移在内的淋巴结转移的总数(ON)和最大直径(LD),提出了三种新的 N 分期方案;通过赤池信息量准则(AIC)、贝叶斯信息量准则(BIC)和 Nagelkerke 伪 R 比较其与现行 TNM 分期的性能。
腮腺内淋巴结、ON 和 LD 是影响 OS 的主要预后因素,而淋巴结外侵犯对任何生存均无影响。现行 N 分期对 OS 分层无满意效果。根据转移淋巴结的数量(0 对 1-3 对≥4)和/或最大直径(<20mm 对≥20mm)提出了三种新的 N 分期。与现行 N 分期相比,所有新的 N 分期均能更好地分层 OS,且 AIC、BIC 和 Nagelkerke 伪 R 指数也更好。
所有提出的 N 分期均改善了 OS 分层,有助于为 MSG 癌定义特定的 N 分期。需要在外部队列中对其进行验证和评估。